Mesothelioma
📧 Sign up to get email alerts when something new happens for Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
A pilot clinical trial investigating the role of gut flora in metastatic mesothelioma has been withdrawn.
-
EMA withdrawal · 2021-11-26EMA Withdrawn: Pemetrexed Lilly (pemetrexed) — Eli Lilly Netherlands
Pemetrexed Lilly (pemetrexed) was withdrawn from EMA evaluation across indications for non-small cell lung cancer and mesothelioma.
-
EMA withdrawal · 2021-07-29EMA Withdrawn: Pemetrexed Pfizer (previously Pemetrexed Hospira UK Limited) (pemetrexed ditromethamine) — Pfizer Europe MA EEIG
The EMA status indicates the pemetrexed product previously marketed by Hospira/Pfizer has been withdrawn. It was indicated for non-small cel…
-
CLINICAL_TRIALS withdrawal · 2018-04-17Clinical Trial Update: Pulmonary Interstitial Lymphography in Early Stage Lung Cancer [NA]
The Stanford University-sponsored trial 'Pulmonary Interstitial Lymphography in Early Stage Lung Cancer' has been terminated. The trial stat…
-
EMA withdrawal · 2018-02-08EMA Application withdrawn: Zafiride — MolMed SpA
The EMA withdrew the application for Zafiride by MolMed SpA; the therapeutic area was mesothelioma and the status indicates the application …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2016-12-21EMA Application withdrawn: Pemetrexed ditromethamine Hospira (pemetrexed ditromethamine)
The EMA withdrew the application for pemetrexed ditromethamine Hospira, a pemetrexed conjugate, for mesothelioma and non-small cell lung car…
-
CLINICAL_TRIALS withdrawal · 2016-12-07Clinical Trial Update: A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients [Phase 1, Phase 2]
This Phase 1/Phase 2 trial evaluating CDX-1401 in combination with Poly-ICLC and pembrolizumab for previously treated advanced solid tumors …
-
CLINICAL_TRIALS withdrawal · 2015-06-25Clinical Trial Update: CryoSpray Ablation(tm)Thoracic Patient Registry
A thoracic patient registry evaluating CryoSpray Ablation has been withdrawn from the trial registry. The study covered conditions including…